Abstract:In DNA vaccination, CD4(+) T-cell help can be enhanced by fusion of a gene encoding an immunization protein with a foreign gene or its part providing T(h) epitopes. To study the effect of helper epitope localization in a protein molecule, the influence of the vicinity of the helper epitope, and the impact of chimeric protein cellular localization, we fused the helper epitope p30 from tetanus toxin (TT, aa 947-967) with the N- or C-terminus of the mutated E7 oncoprotein (E7GGG) of human papillomavirus type 16, … Show more
“…Several reports indicated that Th epitopes are capable of increasing the immunogenicity of CTL epitope-based vaccines, 34 and, as such, some universal Th epitopes were previously incorporated into such vaccines. 34,35 In this work, Th epitopes were included as part of the multi-epitope vaccine to induce better immune responses.…”
Section: Discussionmentioning
confidence: 99%
“…34,35 In this work, Th epitopes were included as part of the multi-epitope vaccine to induce better immune responses. In contrast other studies, HIV-1-specific Th epitopes, rather than universal Th epitopes, were chosen for 2 reasons.…”
“…Several reports indicated that Th epitopes are capable of increasing the immunogenicity of CTL epitope-based vaccines, 34 and, as such, some universal Th epitopes were previously incorporated into such vaccines. 34,35 In this work, Th epitopes were included as part of the multi-epitope vaccine to induce better immune responses.…”
Section: Discussionmentioning
confidence: 99%
“…34,35 In this work, Th epitopes were included as part of the multi-epitope vaccine to induce better immune responses. In contrast other studies, HIV-1-specific Th epitopes, rather than universal Th epitopes, were chosen for 2 reasons.…”
“…31 Cellular localization of the Aurka protein was changed by the sorting sequences of the LAMP-1 protein that have been published to enhance immunogenicity of other antigens. 31 Cellular localization of the Aurka protein was changed by the sorting sequences of the LAMP-1 protein that have been published to enhance immunogenicity of other antigens.…”
Section: Discussionmentioning
confidence: 99%
“…This combined immunotherapy significantly inhibited the growth of TC-1induced tumors, but only when a single dose of anti-CD25 was applied (Fig. 31 Similar to the PADRE.mutAurka gene in preventive immunization, the PADRE.E7GGG gene reduced tumor growth only in combination with a single anti-CD25 dose (Fig. In therapeutic immunization against TC-1 cells, when the PADRE.mutAurka DNA vaccine was applied 3, 7, and 10 days after TC-1 inoculation and antibody against CD25 was injected on days of immunization or 2 days before TC-1 inoculation, DNA vaccination alone or combined with anti-CD25 did not influence tumor growth (Fig.…”
Section: Depletion Of Cd25 + Cells Enhanced the Efficacy Of Dna Vaccimentioning
confidence: 93%
“…For all amplifications, Phusion High-Fidelity DNA Polymerase (Finnzymes, Espoo, Finland) 31 was used, and the constructed genes were verified by sequencing.…”
Aurora kinase A (AURKA) is a centrosomal protein that is overexpressed in a number of human malignancies and can contribute to tumor progression. As we used this protein as a target of DNA immunization, we increased its immunogenicity by the addition of the PADRE helper epitope and decreased its potential oncogenicity by mutagenesis of the kinase domain. For in vitro analysis of induced immune responses in mice, we identified the Aurka(220-228) nonapeptide representing an H-2Kb epitope. As DNA vaccination against the Aurka self-antigen by a gene gun did not show any antitumor effect, we combined DNA immunization with anti-CD25 treatment that depletes mainly regulatory T cells. Whereas 1 anti-CD25 dose injected before DNA vaccination did not enhance the activation of Aurka-specific splenocytes, 3 doses administered on days of immunizations augmented about 10-fold immunity against Aurka. However, an opposite effect was found for antitumor immunity-only 1 anti-CD25 dose combined with DNA vaccination reduced tumor growth. Moreover, the administration of 3 doses of anti-CD25 antibody alone accelerated tumor growth. Analysis of tumor-infiltrating cells showed that 3 anti-CD25 doses not only efficiently depleted regulatory T cells but also activated helper T cells and CD3(-)CD25(+) cells. Next, we found that blockade of the PD-1 receptor initiated 1 week after the first immunization was necessary for significant inhibition of tumor growth with therapeutic DNA vaccination against Aurka combined with depletion of CD25 cells. Our results suggest that combined cancer immunotherapy should be carefully evaluated to achieve the optimal antitumor effect.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.